TCR2 THERAPEUTICS INC's ticker is TCRR and the CUSIP is 87808K106. A total of 58 filers reported holding TCR2 THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q1 2023 | $4,575 | +50.2% | 3,050 | 0.0% | 0.00% | – |
Q4 2022 | $3,046 | -39.1% | 3,050 | 0.0% | 0.00% | -100.0% |
Q3 2022 | $5,000 | -44.4% | 3,050 | 0.0% | 0.00% | 0.0% |
Q2 2022 | $9,000 | +12.5% | 3,050 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $8,000 | -42.9% | 3,050 | 0.0% | 0.00% | -50.0% |
Q4 2021 | $14,000 | – | 3,050 | – | 0.00% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
MPM ASSET MANAGEMENT LLC | 4,050,865 | $4,046,814 | 1.69% |
MPM BioImpact LLC | 3,370,982 | $3,367,611 | 0.87% |
TANG CAPITAL MANAGEMENT LLC | 2,738,947 | $2,735,660 | 0.40% |
Newtyn Management, LLC | 1,075,000 | $1,073,710 | 0.22% |
HARBOR CAPITAL ADVISORS, INC. | 68,230 | $68,148 | 0.07% |
Artal Group S.A. | 750,000 | $749 | 0.04% |
Oasis Management Co Ltd. | 200,000 | $199,760 | 0.04% |
Redmile Group, LLC | 731,379 | $730,501 | 0.03% |
X-Square Capital, LLC | 31,919 | $32 | 0.02% |
CORNERCAP INVESTMENT COUNSEL INC | 68,035 | $67,953 | 0.01% |